Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 2
1968 4
1970 2
1971 1
1972 4
1973 2
1974 2
1975 11
1976 11
1977 6
1978 13
1979 13
1980 9
1981 14
1982 10
1983 11
1984 12
1985 9
1986 13
1987 11
1988 11
1989 9
1990 9
1991 9
1992 12
1993 6
1994 12
1995 6
1996 7
1997 10
1998 11
1999 10
2000 5
2001 13
2002 4
2003 12
2004 13
2005 7
2006 8
2007 12
2008 9
2009 5
2010 7
2011 16
2012 13
2013 17
2014 14
2015 10
2016 14
2017 15
2018 23
2019 19
2020 25
2021 35
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

552 results
Results by year
Filters applied: . Clear all
Page 1
Ketogenic Diets for Adult Neurological Disorders.
McDonald TJW, Cervenka MC. McDonald TJW, et al. Neurotherapeutics. 2018 Oct;15(4):1018-1031. doi: 10.1007/s13311-018-0666-8. Neurotherapeutics. 2018. PMID: 30225789 Free PMC article. Review.
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Kennedy NA, Lin S, Goodhand JR, Chanchlani N, Hamilton B, Bewshea C, Nice R, Chee D, Cummings JF, Fraser A, Irving PM, Kamperidis N, Kok KB, Lamb CA, Macdonald J, Mehta S, Pollok RC, Raine T, Smith PJ, Verma AM, Jochum S, McDonald TJ, Sebastian S, Lees CW, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Among authors: mcdonald tj. Gut. 2021 Oct;70(10):1884-1893. doi: 10.1136/gutjnl-2021-324789. Epub 2021 Apr 26. Gut. 2021. PMID: 33903149 Free PMC article.
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N, Walker GJ, Perry MH, McDonald TJ, Lees CW, Cummings JRF, Parkes M, Mansfield JC, Irving PM, Barrett JC, McGovern D, Goodhand JR, Anderson CA, Ahmad T; PANTS Consortium. Sazonovs A, et al. Among authors: mcdonald tj. Gastroenterology. 2020 Jan;158(1):189-199. doi: 10.1053/j.gastro.2019.09.041. Epub 2019 Oct 7. Gastroenterology. 2020. PMID: 31600487 Free article.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Among authors: mcdonald tj. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
A high-sensitivity electrochemiluminescence-based ELISA for the measurement of the oxidative stress biomarker, 3-nitrotyrosine, in human blood serum and cells.
Knight AR, Taylor EL, Lukaszewski R, Jensen KT, Jones HE, Carré JE, Isupov MN, Littlechild JA, Bailey SJ, Brewer E, McDonald TJ, Pitt AR, Spickett CM, Winyard PG. Knight AR, et al. Among authors: mcdonald tj. Free Radic Biol Med. 2018 May 20;120:246-254. doi: 10.1016/j.freeradbiomed.2018.03.026. Epub 2018 Mar 17. Free Radic Biol Med. 2018. PMID: 29555590
Investigating hyperkalaemia in adults.
McDonald TJ, Oram RA, Vaidya B. McDonald TJ, et al. BMJ. 2015 Oct 20;351:h4762. doi: 10.1136/bmj.h4762. BMJ. 2015. PMID: 26487322 Review. No abstract available.
Investigating hypokalaemia.
Oram RA, McDonald TJ, Vaidya B. Oram RA, et al. Among authors: mcdonald tj. BMJ. 2013 Sep 24;347:f5137. doi: 10.1136/bmj.f5137. BMJ. 2013. PMID: 24065427 No abstract available.
552 results